Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.
Agilon (AGL) Moves 26.1% Higher: Will This Strength Last?
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.
AGL Energy Limited (AGLNF) Q2 2025 Earnings Conference Call Transcript
AGL Energy Limited (OTCPK:AGLNF) Q2 2025 Earnings Conference Call February 11, 2025 7:00 PM ET Company Participants Damien Nicks - MD and CEO Gary Brown - CFO Jo Egan - Chief Customer Officer Markus Brokhof - COO Conference Call Participants Tom Allen - UBS Dale Koenders - Barrenjoey Anthony Moulder - Jefferies Rob Koh - Morgan Stanley Gordon Ramsay - RBC Capital Markets Ian Myles - Macquarie Henry Meyer - Goldman Sachs Operator Thank you for standing by, and welcome to the AGL Energy Half Year Results Briefing Conference Call. All participants will be in listen-only mode.
New Strong Sell Stocks for January 28th
AGL, ASHTY and CCOZY have been added to the Zacks Rank #5 (Strong Sell) List on January 28, 2024.
New Strong Sell Stocks for January 24th
WMS, AGL and EADSY have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2025.
New Strong Sell Stocks for January 21st
VLVLY, AGL and APOG have been added to the Zacks Rank #5 (Strong Sell) List on January 21, 2025.
